Summary
The insulin receptor is a heterotetrameric structure consisting of two α-subunits of Mr135 kilodalton on the outside of the plasma membrane connected by disulphide bonds to β-subunits of Mr95 kilodalton which are transmembrane proteins. Insulin binding to the α-subunit induces conformational changes which are transduced to the β-subunit. This leads to the activation of a tyrosine kinase activity which is intrinsic to the cytoplasmatic domains of the β-subunit. Activation of the tyrosine kinase activity of the insulin receptor represents an essential step in the transduction of an insulin signal across the plasma membrane of target cells. Signal transduction on the post-kinase level is not yet understood in detail, possible mechanisms involve phosphorylation of substrate proteins at tyrosine residues, activation of serine kinases, the interaction with G-proteins, phospholipases and phosphatidylinositol kinases. Studies in multiple insulin-resistant cell models have demonstrated that an impaired response of the tyrosine kinase to insulin stimulation is one potential mechanism causing insulin resistance. An impairment of the insulin effect on tyrosine kinase activation in all major target tissues of insulin, in particular the skeletal muscle was demonstrated in Type 2 (non-insulin-dependent) diabetic patients. There is no evidence that the impaired tyrosine kinase response in the skeletal muscle is a primary defect, however, it is likely that this abnormality of insulin signal transduction contributes significantly to the pathogenesis of the insulin-resistant state in Type 2 diabetes.
Article PDF
Similar content being viewed by others
References
Reaven GM, Bernstein R, Davis B, Olefsky JM (1976) Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med 60: 80–88
De Fronzo RA (1988) The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667–687
Reaven GM (1983) Insulin resistance in noninsulin-dependent diabetes mellitus. Does it exist and can it be measured? Am J Med 74: 3–17
Olefsky JM, Ciaraldi TP, Kolterman OG (1985) Mechanism of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med 79: 12–22
Olefsky JM (1981) Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes 30: 148–162
Eriksson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes melllitus. N Engl J Med 321: 337–343
Warram JH, Martin BH, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow removal rate and hyperinsulinaemia precede the development of type II diabetes in the offspring of diabetic patients. Ann Intern Med 113: 909–1015
Freychet P, Kahn CR, Jarrett DB, Roth J (1971) Insulin receptors in the liver: specific binding of 125I-insulin to the plasma membrane and its relations to insulin bioactivity. Proc Natl Acad Sci 68: 1833–1837
Cuatrecasas P (1971) Insulin receptor interactions in adipose tissue cells: direct measurement and properties. Proc Natl Acad Sci 68: 1264–1268
Kono T, Barham FW (1971) The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin. J Biol Chem 246: 6210–6216
Kasuga M, Karlsson FA, Kahn CR (1982) Insulin stimulates the phosphorylation of the 95.000 Dalton subunit of its own receptor. Science 215: 185–187
Häring HU, Obermaier-Kusser B (1990) The insulin receptor: its role in insulin action and in the pathogenesis of insulin resistance. Diabetes Ann 5: 537–567
Kasuga M, Zick Y, Blithe DL, Karlsson FA, Häring HU, Kahn CR (1982) Insulin stimulation of phosphorylation of the β-subunit of the insulin receptor. J Biol Chem 257: 9891–9894
Häring HU, Kasuga M, Kahn CR (1982) Insulin receptor phosphorylation in intact adipocytes and in a cell-free system. Biochem Biophys Res Commun 108: 1538–1545
VanObberghen E, Kowalski A (1982) Phosphorylation of the hepatic insulin receptor. FEBS Lett 143: 179–192
Häring HU, Kasuga M, White MF, Crettaz M, Kahn CR (1984) Phosphorylation and dephosphorylation of the insulin receptor: evidence against an intrinsic phosphatase activity. Biochemistry 23: 3298–3306
Kasuga M, Fujita-Yamaguchi Y, Blithe DL, Kahn CR (1985) Tyrosine-specific protein kinase activity is associated with the purified insulin receptor. Proc Natl Acad Sci USA 80: 2137–2141
VanObberghen E, Rossi B, Kowalski A, Gazzano H, Ponzio G (1983) Receptor-mediated phosphorylation of the hepatic insulin receptor, evidence that the M=95.000 receptor subunit is its own kinase. Proc Natl Acad Sci USA 80: 945–949
Shia MA, Pilch PF (1983) The β-subunit of the insulin receptor is an insulin-activated protein kinase. Biochemistry 22: 717–721
Ullrich A, Bell JR, Chen EY et al. (1985) Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313: 756–761
Ebina Y, Ellis L, Jarragin K et al. (1985) The human insulin receptor c-DNA: the structural basis for hormone-activated transmembrane signalling. Cell 40: 747–758
Seino S, Seino M, Nishi S, Bell GI (1989) Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci USA 86: 114–118
Moller DE, Yokota A, Caro JF, Flier JS (1989) Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3: 1263–1269
Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA (1990) Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 9: 2409–2414
Hedo JA, Kasuga M, VanObberghen E, Roth J, Kahn CR (1981) Direct demonstration of glycosylation of insulin receptor subunits by biosynthetic and external labelling: evidence for heterogeneity. Proc Natl Acad Sci USA 78: 4791–4795
DeMeyts P, Gu JL, Shymko RM, Bell G, Whittaker J (1988) Identification of an insulin receptor binding domain complementary to the cooperative site of insulin. Diabetologia 31: 484 (Abstract)
DeMeyts P, Gu JL, Katuria S, Shymko RM, Kaplan B, Smal J (1989) Insulinomimetic properties of a synthetic insulin receptor α-subunit binding domain. Diabetes 38 [Suppl 2]: 1 (Abstract)
Yip CC, Hsu H, Patel RG, Hawley DM, Maddux A, Goldfine ID (1988) Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor α-subunit. Biochem Biophys Res Commun 157: 321–329
Rafaeloff R, Patel RG, Yip CC, Hawley DM (1989) Effects of site-specific mutations of the insulin-binding site in the cysteinrich domain of the insulin receptor α-subunit. Diabetes 38 [Suppl 2]: 1 (Abstract)
Matsushime H, Wang L, Shibuya M (1986) Human c-ros-1 gene homologeous to the v-ros sequence of UR2 sarcoma virus encodes for a transmembrane receptor-like molecule. Mol Cell Biol 6: 3000–3004
Anderson SK, Gibbs CP, Tanaka A, Kung H (1985) Human cellular src gene: nucleotide sequence and derived amino acid sequence of the region coding for the carboxy-terminal two-thirds of pp60 c-src. Mol Cell Biol 5: 1122–1129
Semba K, Kamata N, Toyoshima K, Yamamoto T (1985) A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 82: 6497–6501
White MF, Häring HU, Kasuga M, Kahn CR (1984) Kinetic properties and sites of autophosphorylation of the partially purified insulin receptor from hepatoma cells. J Biol Chem 259: 255–264
White MF, Takayama S, Kahn CR (1985) Differences in the sites of phosphorylation of the insulin receptor in vivo and in vitro. J Biol Chem 260: 9470–9478
Tornqvist HE, Pierce MW, Frackelton AR (1987) Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J Biol Chem 262: 10212–10219
Tornqvist HE, Cunsalus JR, Nemenoff RA, Frackelton AR, Pierce MW, Avruch J (1988) Identification of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cells. J Biol Chem 263: 350–359
Tornqvist HE, Avruch J (1988) Relationship of site-specific β-subunit tyrosine autophosphorylation to insulin activation of the insulin receptor (tyrosine) protein kinase activity. J Biol Chem 263: 4593–4601
Tavare JM, Denton RM (1988) Studies on the autophosphorylation of the insulin receptor from human placenta. Analysis of the sites phosphorylated by two-dimensional peptide mapping. Biochem J 252: 607–615
Tavare JM, O'Brien RM, Siddle K, Denton RM (1988) Analysis of insulin-receptor phosphorylation sites in intact cells by two-dimensional phosphopeptide mapping. Biochem J 253: 783–788
White MF, Livingston JN, Backer JM et al. (1988) Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 45: 641–649
White MF, Shoelson SE, Keutmann H, Kahn R (1988) A cascade of tyrosine autophosphorylation in the β-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem 263: 2969–2980
Ellis L, Clauser E, Morgan DO, Edery M, Roth A, Rutter WJ (1986) Replacement of insulin receptor residues 1162 and 1163 compromises insulin stimulated kinase activity and uptake of 2-deoxy glucose. Cell 45: 721–732
Debant A, Clauser E, Ponzio G et al. (1988) Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc Natl Acad Sci USA 85: 8032–8036
Ebina Y, Araki E, Taira M et al. (1987) Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci USA 84: 704–708
Goren HJ, White MF, Kahn CR (1987) Separate domains of the insulin receptor contain sites of autophosphorylation and tyrosine kinase activity. Biochemistry 26: 2374–2382
Herrera R, Lebwohl D, Garcia de Herreros A, Kallen RG, Rosen OM (1988) Synthesis, purification, and characterization of the cytoplasmic domain of the human insulin receptor using a baculovirus expression system. J Biol Chem 263: 5560–5568
Maegawa H, McClain DA, Freidenberg G et al. (1988) Properties of a human insulin receptor with a COOH-terminal truncation, II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects. J Biol Chem 263: 8912–8917
McClain DA, Maegawa H, Levy J et al. (1988) Properties of a human insulin receptor with a COOH-terminal truncation. Insulin binding, autophosphorylation, and endocytosis. J Biol Chem 263: 8904–8911
Lewis RE, Perregaux DG, Perregaux SB (1989) Insulin-stimulated serine/threonine phosphorylation of insulin receptor in vitro is due to enhanced catalytic activity of an associated serine kinase (IRSK). Diabetes 38 [Suppl 2]: 1 (Abstract)
Lewis RE, Perrigaux S, Perrigaux D, Whittaker J, Czech MP (1990) Insulin receptor regulation by serine/threonine phosphorylation: analysis of receptor threonine 1336 mutant in a transient expression system. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, pp 119–120
Backer JM, Ullrich A, Kahn CR, White MF (1990) Receptor-mediated internalization of insulin requires a 12 amino acid sequence in the juxtamembrane region of the receptor β-subunit. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, pp 14–15
Chen WJ, Goldstein JL, Broom MS (1990) NPX, a sequence often found in cytoplasmic tails, is required for coated pit mediated internalization of the low density lipoprotein receptor. J Biol Chem 265: 3116–3123
Kellerer M, Ermel B, Vogt B, Obermaier-Kusser B, Ullrich A, Häring HU (1990) Different α-subunit structure of type A and B human insulin receptor determines different tyrosine kinase activities. Diabetologia 33 [Suppl]: 35 (Abstract)
Vogt B, Carrascosa JM, Ermel B, Ullrich A, Häring HU (1991) The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem Biophys Res Commun 177: 1013–1088
Johnson JD, Wong ML, Rutter WJ (1988) Properties of the insulin-receptor ectodomain. Proc Natl Acad Sci USA 85: 7516–7520
Sweet LJ, Morrison BD, Wilden PA, Pessin JE (1987) Insulindependent intermolecular subunit communication between isolated α-β heterodimeric insulin receptor complexes. J Biol Chem 262: 16730–16738
O'Hare T, Pilch PF (1988) Separation and characterization of three insulin receptor species that differ in subunit composition. Biochemistry 27: 5693–5700
Kahn CR (1985) The molecular mechanism of insulin action. Ann Rev Med 36: 429–451
Debant A, Ponzio G, Clauser E, Contreres JO, Rossi B (1989) Receptor crosslinking restores an insulin metabolic effect altered by mutation on tyrosine (1162) and tyrosine 1163. Biochemistry 28: 14–17
Frias I, Waugh SM (1989) Probing the α-α subunit interface region in the insulin receptor, location of interhalf disulfide(s). Diabetes 38 [Suppl 2]: 60 (Abstract)
Shoelson SE, White MF, Kahn CR (1988) Tryptic activation of the insulin receptor. Proteolytic truncation of the α-subunit releases the β-subunit from inhibitory control. J Biol Chem 263: 4852–4860
Prigent SA, Ganderton RH, Soos MA, Stanley KK, Siddle K (1990) Site-specific antibodies as probes of insulin receptor: structure and function. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, pp 166–167
Gherzi R, Sesti G, Andraghetti G et al. (1989) An extracellular domain of the insulin receptor β-subunit with regulatory function on protein-tyrosine kinase. J Biol Chem 264: 8627–8635
Maddux BA, Goldfine ID (1990) Evidence that insulin plus ATP can induce a conformational change in the β-subunit of the insulin receptor without inducing receptor autophosphorylation. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects.
Baron V, Gautier N, Hainaut P, Scimeca JC, Dolais-Kitabgi J, VanObberghen E (1990) Insulin binding to its receptor induces a conformational change in the receptor C-terminus. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, pp 20–21
Kellerer M, Ermel B, Vogt B, Ullrich A, Häring HU (1990) Different α-subunit structures of the human insulin receptors type A and B affect the tyrosine kinase activity of the β-subunit. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, p 103
Accili D, Kadowaki T, Mosthaf L, Ullrich A, Taylor SI (1990) Molecular basis of insulin resistance in patients with genetic forms of extreme insulin resistance. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, pp 5–6
Ballotti R, Baron V, Gautier N et al. (1990) Activation and regulation of the insulin receptor kinase. Hormones and cell regulation. Colloque Inserm 210: 29–36
White MF, Maron R, Kahn CR (1985) Insulin rapidly stimulates tyrosine phosphorylation of a 185.000 molecular weight protein in intact cells. Nature 163: 76–80
Häring HU, White MF, Machicao F, Ermel B, Schleicher E, Obermaier B (1987) Insulin rapidly stimulates phosphorylation of a 46 kDa membrane protein on tyrosine residues as well as a phosphorylation of several soluble proteins in intact fat cells. Proc Natl Acd Sci USA 84: 113–117
Machicao F, Häring H, White MF, Carrascosa JM, Obermaier B, Wieland OH (1987) A 180,000 molecular weight protein is an endogenous substrate for the insulin receptor associated tyrosine kinase in human placenta. Biochem J 243: 797–801
Rees-Jones R, Taylor S (1985) An endogenous substrate for the insulin receptor-associated tyrosine kinase. J Biol Chem 260: 4461–4467
Sedoul JC, Pegron JF, Ballotti R, Debant A, Fehlmann M, VanObberghen E (1985) Identification of a cellular 110.000 Da protein substrate for the insulin-receptor kinase. Biochem J 227: 887–892
Momomura K, Topa K, Seyama Y, Takaku F, Kasuga M (1988) Insulin induced tyrosine-phosphorylation in intact rat adipocytes. Biochem Biophys Res Commun 155: 1181–1186
Margolis RN, Taylor SI, Seminara D, Hubbard AL (1988) Identification of pp120, an endogenous substrate for hepatocyte insulin receptor tyrosine kinase, as an integral membrane glycoprotein of the bile canalicular domain. Proc Natl Acad Sci USA 85: 7256–7259
Bernier M, Laird DM, Lane DM (1987) Insulin activated tyrosine phosphorylation of a 15 kilodalton protein in intact 3T3-L1 adipocytes. Proc Natl Acad Sci USA 84: 1844–1848
Hoffmann RD, Flores-Riveros JR, Liao K, Laird DM, Lane MD (1988) Identification of phosphorylated 422(aP2) protein as pp15, the 15-kilodalton target of the insulin receptor tyrosine kinase in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 85: 8835–8839
Izumi T, White MF, Kadowaki T, Takaku F, Akanuma Y, Kasuga M (1987) Insulin-like growth factor I rapidly stimulates tyrosine phosphorylation of a Mr 185.000 protein in intact cells. J Biol Chem 262: 1282–1287
Madoff DH, Martensen TM, Lane DM (1988) Insulin and insulin-like growth factor I stimulate the phosphorylation on tyrosine of a 160 kDa cytosolic protein in 3T3-L1 adipocytes. Biochem 1252: 7–15
Obermaier-Kusser B, Ermel B, Mühlbacher C, Häring HU (1988) A Mr60 kDa serine kinase: substrate of the insulin receptor kinase in vitro and in the intact cell. Diabetes Res Clin Pract 60 [Suppl 1]: 67–93
Häring HU, White MF, Kahn CR, Ahmad Z, DePaoli-Roach AA, Roach PJ (1985) Interaction of the insulin receptor kinase with serine/threonine kinases in vitro. J Cell Biochem 28: 171–182
Laurino JP, Colca JR, Pearson JD, De Wald DB, McDonald JM (1988) The in vitro phosphorylation of calmodulin by the insulin receptor tyrosine kinase. Arch Biochem Biophys 265: 8–21
Nong ECC, Eacks DB, Laurino JF, McDonald JM (1988) Characteristics of calmodulin phosphorylation by the insulin receptor kinase. Endocrinology 123: 1830–1836
Rothenberg PL, Lane WS, Karasik A, Backer J, White MF, Kahn CR (1991) Purification and partial sequence analysis of pp185. the major cellular substrate of the insulin receptor tyrosine kinase. J Biol Chem 266: 8302–8311
Häring HU, Kirsch D, Obermaier B, Ermel B, Machicao F (1986) Decreased tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin-resistant by catecholamine treatment in vitro. Biochem J 234: 59–66
Häring HU, Kirsch D, Obermaier B, Ermel B, Machicao F (1986) Tumor promoting phorbolesters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes. J Biol Chem 261: 3869–3875
Obermaier B, Ermel B, Kirsch D et al. (1987) Catecholamines and tumour promoting phorbolesters inhibit insulin receptor kinase and induce insulin resistance in isolated human adipocytes. Diabetologia 30: 93–99
Jacobs S, Sahyoun NE, Saltiel AR, Cuatrecasas P (1983) Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin. Proc Natl Acad Sci USA 80: 6211–6213
Takayama S, White MF, Lauris V, Kahn CR (1984) Phorbol ester modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells. Proc Nat Acad Sci USA 81: 7797–7801
Takayama S, White MF, Kahn CR (1988) Phorbol ester induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 263: 3340–3447
Kellerer M, Seffer E, Mushack J, Obermaier-Kusser B, Häring HU (1990) TPA inhibits insulin stimulated PIP hydrolysis in fat cell membranes: evidence for modulation of insulin dependent phospholipase C by proteinkinase C. Biochem Biophys Res Commun 172: 446–454
Lewis RE, Perregaux DG, Perregaux SB (1989) Insulin stimulated serine/threonine phosphorylation of insulin receptor in vitro is due to enhanced catalytic activity of an associated serine kinase (IRSK). Diabetes 38: [Suppl 2]: 1 (Abstract)
Ray BL, Sturgill TW (1988) Insulin stimulated microtubuleassociated protein kinase is phosphorylated on tyrosine and threonine in vivo. Proc Natl Acad Sci USA 85: 3753–3757
Gazzano H, Kowalski A, Fehlmann M, VanObberghen E (1988) Two different protein kinase activities are associated with the insulin receptor. Biochem J 216: 575–582
Yu KT, Khalaf N, Czech MP (1987) Insulin stimulates a membrane-bound serine kinase that may be phosphorylated on tyrosine. Proc Natl Acad Sci USA 84: 3972–3976
Smith DM, King MJ, Sale GJ (1988) Two systems in vitro that show insulin-stimulated serine kinase activity toward the insulin receptor. Biochem J 250: 509–519
Klarlund JK, Bradford AP, Yu K et al. (1990) Intracellular signalling by the insulin receptor: characterization of a novel kemptide, insulin-sensitive, protein kinase (KIK) In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, pp 107–108
Kirsch D, Obermaier B, Häring HU (1985) Phorbolesters enhance basal D-glucose transport but inhibit insulin stimulation of D-glucose transport and insulin binding in isolated rat adipocytes. Biochem Biophys Res Commun 128: 824–832
Mühlbacher C, Karnieli E, Schaff P et al. (1988) Phorbol esters imitate in rat fat-cells the full effect of insulin on glucose-carrier translocation, but not on 3-O-methyl-glucose transport activity. Biochem J 249: 865–870
Farese RV, Vila M, Hoffmann J et al. (1990) Phospholipid signalling systems in insulin action. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, pp 72–73
Cooper DR, Ishizuka T, Dao ML, Watson JE, Standaert ML, Farese RV (1990) Regulation of protein kinase C by insulin and diacylglycerol. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, p 52
Vogt B, Mushack J, Seffer E, Häring HU (1990) The phorbol ester TPA induces a translocation of the insulin sensitive glucose carrier (GLUT4) in fat cells. Biochem Biophys Res Commun 168: 1089–1094
Vogt B, Mushack J, Seffer E, Häring HU (1991) The translocation of the glucose transporter subtypes GLUT1 and GLUT4 in isolated fat cells is differently regulated by phorbol esters. Biochem J 275: 597–600
Machicao F, Wieland OH (1984) Evidence that the insulin receptor-associated protein kinase acts as phosphatidylinositol kinase. FEBS Lett 175: 113–116
Sale J, Fujita-Yamaguchi Y, Kahn CR (1986) Characterization of phosphatidyl kinase activity associated with the insulin receptor. Eur J Biochem 155: 345–351
Carrascosa J, Schleicher E, Maier R, Hackenberg C, Wieland OH (1988) Separation of the protein-tyrosine kinase and phosphatidylinositol kinase activities of the human placental insulin receptor. Biochem Biophys Acta Ser Mol Cell Res 971: 170–178
Backer JM, Ullrich A, Kahn CR, White MF (1990) Receptor-mediated internalization of insulin requires a 12 amino acid sequence in the juxtamembrane region of the insulin receptor β-subunit. In: Bonora E, Cigolini M, Moghetti P, Zoppini G (eds) IV International symposium on insulin receptor and insulin action. Molecular and clinical aspects, pp 14–15
Carrascosa JM, Vogt B, Ullrich A, Häring HU (1991) Activation of phosphatidylinositol-3 kinase by insulin is mediated by both A and B human insulin receptor. Biochem Biophys Res Commun 174: 123–127
Heyworth CM, Houslay MD (1983) Insulin exerts actions through a distinct species of guanine nucleotide regulatory protein: inhibition of adenylate cyclase. Biochem J 214: 547–552
Heyworth CM, Whetton AD, Wong S, Martin BR, Houslay MD (1985) Insulin inhibits the cholera-toxin-catalysed ribosylation of a Mr 25000 protein in rat liver plasma membranes. Biochem J 228: 593–603
Rothenberg PL, Kahn CR (1988) Insulin inhibits pertussis toxin-catalyzed ADP-ribosylation of G-proteins. Evidence for a novel interaction between insulin receptors and G-proteins. J Biol Chem 263: 15546–15552
Gawler D, Milligan G, Spiegel AM, Unson LG, Houslay MD (1987) Abolition of the expression of inhibitory guanine nucleotide regulatory protein G1 activity in diabetes. Nature 327: 229–232
O'Brian RM, Houslay MD, Milligan G, Siddle K (1987) The insulin receptor tyrosyl kinase phosphorylates holomeric forms of the guanine nucleotide regulatory proteins Gi and Go. FEBS Lett 212: 281–288
Krupinski J, Rajaram R, Lakonishok M, Benovic JL, Cerione RA (1988) Insulin-dependent phosphorylation of GTP-binding proteins in phospholipid vesicles. J Biol Chem 263: 12333–12341
Zick Y, Sagi-Eisenberg R, Pines M, Gierschik P, Spiegel AM (1986) Multisite phosphorylation of the α-subunit of transducin by the insulin receptor kinase and protein kinase C. Proc Natl Acad Sci USA 83: 9294–9297
Obermaier-Kusser B, Mühlbacher C, Mushack J, Rattenhuber E, Fehlmann M, Häring HU (1988) Regulation of glucose carrier activity by AlCl3 and phospholipase C in fat cells. Biochem J 256: 515–520
Kellerer M, Obermaier-Kusser B, Pröfrock A et al. (1991) Insulin activates GTP-binding to a 40,000 Dalton protein in fat cells. Biochem J 276: 103–108
Jo H, Davis HW, McDonald JM (1990) Identification of a GTP-binding protein associated with the insulin receptor. Diabetes 39 [Suppl 1]: 1 (Abstract)
Fox JA, Soliz NM, Saltiel AR (1987) Purification of a phosphatidylinositol-glycan-specific phospholipase C from liver plasma membranes. Proc Natl Acad Sci USA 84: 2663–2667
Koepfer-Hobelsberger B, Wieland OH (1984) Insulin activates phospholipase C in fat cells: similarity with the activation of pyruvate dehydrogenase. Mol Cell Endocrin 36: 123–129
Egan JJ, Saltis J, Wek SA, Simpson IA, Londos C (1990) Insulin, oxytocin, and vasopressin stimulate protein kinase C activity in adipocyte plasma membranes. Proc Natl Acad Sci USA 87: 1052–1056
Yoshimoto A, Nakanishi K, Anzai T, Komine S (1990) The activation of phosphatidylinositol-specific phospholipase C by insulin in mammary epithelial cells of lactating mouse. Cell Biochem Funct 8: 163–166
Cooper DR, Ishizuka T, Dao ML, Watson JE, Standaert ML, Farese RV (1990) Regulation of protein kinase C by insulin and diacylglycerol. Biochem Biophys Acta 1054: 95–102
Saltiel AR (1987) Insulin generates an enzyme modulator from hepatic plasma membranes: regulation of adenosine 3′5′-monophosphate phosphodiesterase, pyruvate dehydrogenase, and adenylate cyclase. Endocrinology 120: 967–972
Saltiel AR, Cuatrecasas P (1986) Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid. Proc Natl Acad Sci USA 83: 5793–5797
Saltiel AR, Fox JA, Sherkine P, Cuatrecasas P (1986) Insulin stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase. Science 233: 967–972
Mato JM, Kelly KL, Abler A, Jarrett L (1987) Identification of a novel insulin-sensitive glycophospholipid from H35 hepatoma cells. J Biol Chem 262: 2131–2137
Kelly KL, Mato JM, Jarrett L (1986) The polar head group of a novel insulin-sensitive glycophospholipid mimics insulin action on phospholipid methyltransferase. FEBS Lett 209: 238–242
Kelly KL, Mato JM, Merida J, Jarrett L (1987) Glucose transport and antilipolysis are differentially regulated by the polar head group of an insulin-sensitive glycophospholipid. Proc Natl Acad Sci USA 84: 6404–6407
Alemany S, Mato JM, Stralfors P (1987) Phosphodephospho-control by insulin is mimicked by a phosphooligosaccharide in adipocytes. Nature 330: 77–79
Standaert ML, Farese RV, Cooper DR, Pollet RJ (1988) Insulin-induced glycerolipid mediators and the stimulation of glucose transport in BC3H-1 myocytes. J Biol Chem 263: 8698–8705
Mato JM (1989) Insulin mediators revisited. Cell Signal 1: 143–146
Garcia de Herreros A, Birnbaum M (1989) The regulation of the glucose transporter gene expression in 3T3 adipocytes. J Biol Chem 264: 9885–9890
Mückler M (1990) Family of glucose transporter genes. Diabetes 39: 6–11
Fukumoto H, Seino S, Imura H et al. (1988) Sequence tissue distribution and chromosomal location of mRNA encoding a novel human glucose transporter-like protein. Proc Natl Acad Sci USA 85: 5434
Häring H, Biermann E, Kemmler W (1981) Coupling of insulin binding and insulin action on glucose transport in fat cells. Am J Physiol 240: E556-E565
Häring HU, Biermann E, Kemmler W (1982) Relation of insulin receptor occupancy and deactivation of glucose transport. Am J Physiol: E234–E240
Cushman SW, Wardzala LJ (1980) Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. J Cell Biochem 255: 4758–4762
Kono T, Suzuki K, Dansey LE, Robinson FW, Blewis TL (1981) Energy-dependent and protein synthesis-independent recycling of the insulin-sensitive glucose transport mechanism in fat cells. J Biol Chem 256: 6400–6407
Joost HG, Weber TM, Cushman SW, Simpson IA (1986) Insulin stimulated glucose transport in rat adipose cells. J Biol Chem 261: 10017–10020
Kahn BB, Cushman SW (1987) Mechanism for markedly hyperresponsive insulin-stimulated glucose transport activity in adipose cells from insulin-treated streptozotocin diabetic rats. J Biol Chem 262: 5118–5124
Matthaei S, Garvey WT, Horuk R, Hueckstaedt TP, Olefsky JM (1987) Human adipocyte glucose transport system. Biochemical and functional heterogeneity of hexose carriers. J Clin Invest 79: 703–709
Karnieli E, Armoni M, Cohen P, Kanter Y, Rafaeloff R (1987) Reversal of insulin resistance in diabetic rat adipocytes by insulin therapy. Restoration of glucose transporters and enhancement of glucose-transport acitvity. Diabetes 36: 925–931
Obermaier-Kusser B, Mühlbacher C, Mushack J et al. (1989) Further evidence for a two-step model of glucose-transport regulation. Biochem J 261: 699–705
Machicao F, Mushack J, Seffer E, Ermel B, Häring HU (1990) Mannose, glucosamine and inositol monophosphate inhibit the effects of insulin on lipogenesis. Biochem J 266: 909–916
Häring HU, White MF, Kahn CR et al. (1984) Abnormality of insulin binding and receptor phosphorylation in an insulin resistant melanoma cell line. J Cell Biol 99: 900–908
Häring HU, Obermaier B, Ermel B et al. (1987) Insulin receptor kinase defects as a possible cause of cellular insulin resistance. Diabete Metab 13: 284–293
LeMarchand Y, Gremeauy T, Ballotti R (1985) Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice. Nature 315: 676–679
Kadowaki T, Kasuga M, Akanuma Y, Ezaki O, Takaku F (1984) Decreased autophosphorylation of the insulin receptor kinase in streptozotocin-diabetic rats. J Biol Chem 259: 14208–14216
Debant A, Guerre-Millo M, LeMarchand-Brustel Y, Freychet P, Lavar M, VanObberghen E (1987) Insulin receptor kinase is hyperresponsive in adipocytes of young obese Zucker rats. Am J Physiol 252: E273-E278
Bray GA (1977) The Zucker fatty rat: a review. Fed Proc 36: 148–153
Crettaz M, Jeanrenaud B (1980) Progressive establishment of insulin resistance in skeletal muscle of obese rats. Congress of Obesity: 268–274
Gremeaux T, Tanti JF, VanObberghen E, LeMarchand-Brustel Y (1987) Alteration of insulin receptor kinase in obese insulin-resistant mice. Biochimie 69: 387–393
Vicario P, Brady EJ, Slater EE, Saperstein R (1987) Insulin receptor tyrosine kinase activity is unaltered in ob/ob and db/dt mouse skeletal muscle membranes. Life Sci 41: 1233–1241
Ludwig SM, Müller-Wieland D, Goldstein BJ, Kahn CR (1988) The insulin receptor gene and its expression in insulin resistant mice. Endocrinology 123: 594–600
Burant CF, Trentelaar MK, Buse MG (1986) Diabetes induced functional and structural changes in insulin receptors from rat skeletal muscle. J Clin Invest 77: 260–270
Grigorescu F, Flier JS, Kahn CR (1984) Defect in insulin receptor phosphorylation in erythrocytes and fibroblasts associated with severe insulin resistance. J Biol Chem 259: 15003–15006
Grunberger G, Zick Y, Gordon PH (1984) Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patient with normal insulin binding. Science 223: 932–934
Grigorescu F, Flier JS, Kahn CR (1986) Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the type A syndrome of insulin resistance. Diabetes 35: 127–138
Kadowaki T, Bevins CL, Cama A et al. (1988) Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240: 787–790
Kakahi T, Hisatomi A, Kuzuya H et al. (1988) Defective processing of insulin-receptor precursor in cultured lymphocytes from a patient with extreme insulin resistance. J Clin Invest 81: 2020–2022
Kriauciunas KM, Müller-Wieland D, Reddy SSK, Taub R (1988) Altered expression and function of the insulin receptor in a family with lipatrophic diabetes. J Clin Endocrinol Metab 67: 1284–1293
Maassen JA, Klinkhammer MP, Zon GCM Van der et al. (1988) Fibroblasts from a leprechaun patient have defects in insulin binding and insulin receptor autophosphorylation. Diabetologia 31: 612–617
Klinkhammer MP, Groen NA, Zon GCM van der et al. (1989) A leucine-to-proline mutation in the insulin receptor in a family with insulin resistance. EMBO J 8: 2503–2525
Lekanne Deprez RH, Potter van Loon BJ, Zon GCM van der et al. (1989) Individuals with only one allele for a functional insulin receptor have a tendency to hyperinsulinaemia but not to hyperglycaemia. Diabetologia 32: 740–744
Kirsch D, Baumgarten M, Deufel T, Rinninger F, Kemmler W, Häring HU (1983) Catecholamine-induced insulin resistance of glucose transport in isolated rat adipocytes. Biochem J 216: 737–745
Klein HH, Matthaei S, Drenkhan M, Ries W, Scriba PC (1991) The relationship between insulin binding, insulin activation of insulin-receptor tyrosine kinase, and insulin stimulated glucose uptake in isolated rat adipocytes. Biochem J 27: 787–792
Tanti JF, Gremeaux T, Rochet NR, VanObberghen E, LeMarchand-Brustel Y (1987) Effect of cyclic AMP-dependent protein kinase on insulin receptor tyrosine kinase activity. Biochem J 245: 19–26
Roth R, Beaudoin J (1987) Phosphorylation of purified insulin receptor by cAMP-kinase. Diabetes 36: 123–126
Lewis RE, Czech MP (1987) Phospholipid environment alters hormone-sensitivity of the purified insulin receptor kinase. Biochem J 248: 829–836
Ermel B, Vogt B, Obermaier-Kusser B, Häring HU (1989) Hyperglycaemia induced insulin resistance is associated with stimulation of protein kinase C and inhibition of insulin receptor kinase. Diabetologia 32 [Suppl 1]: 485 (Abstract)
Draznin B, Leiter JW, Sussmann KE, Sherman N (1988) Insulin and glucose modulate protein kinase C activity in rat adipocytes. Biochem Biophys Res Commun 156: 570–575
Müller HK, Kellerer M, Ermel B, Mühlhöfer A, Obermaier-Kusser B, Häring HU (in press) Protein kinase C inhibitors prevent glucose induced resistance of the insulin receptor tyrosine kinase in rat fat cells. Diabetes
Ishizuka T, Hoffman J, Cooper DR, Watson JE, Pushkin DB, Farese RV (1989) Glucose-induced synthesis of diacylglycerol de novo is associated with translocation (activation) of protein kinase C in rat adipocytes. FEBS Lett 249: 234–238
Ishizuka T, Cooper DR, Farese RV (1989) Insulin stimulates the translocation of protein kinase C in rat adipocytes. FEBS Lett 257: 337–340
Arsenis G, Livingston JN (1986) Alterations in the tyrosine kinase activity of the insulin receptor produced by in vitro hyperinsulinemia. J Biol Chem 261: 147–153
Sweet LJ, Dudley DT, Pessia JE, Spector AA (1987) Phospholipid activation of the insulin receptor kinase: regulation by phosphatidylinositol. FASEB J 1: 55–59
Rosen OM, Lebwohl DE (1988) Polylysine activates and alters the divalent cation requirements of the insulin receptor protein tyrosine kinase. FEBS Lett 231: 397–401
Klein HH, Ciaraldi TP, Freidenberg GR, Olefsky JM (1987) Adenosine modulates insulin activation of insulin receptor kinase in intact rat adipocytes. Endocrinology 120: 2339–2345
Morrison BD, Feltz SM, Pessin JE (1989) Polylysine activation of insulin dependent insulin receptor protein kinase. Diabetes 38 [Suppl 2]: 60 (Abstract)
Auberger P, Falquerho L, Contreres JO et al. (1989) Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic action. Cell 58: 631–640
Caro JF, Cecchin F, Folli F, Marchini C, Binha MK (1988) Effect of T&D3 primary cultures of rat hepatocytes. Horm Metab Res 20: 327–332
Suthijuroon A, Toth EL, Crockford PM, Ryan EA (1988) Insulin action is altered in hyperthyroidism. Clin Invest Med 11: 435–440
Freidenberg GR, Henry RR, Klein HH, Olefsky JM (1987) Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. Clin Invest 79: 240–250
Freidenberg GR, Reichart D, Olefsky JM, Henry RR (1988) Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. J Clin Invest 82: 1398–1406
Caro JF, Sinha MK, Raju SJ et al. (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin-dependent diabetes. J Clin Invest 79: 1330–1337
Caro JF, Ittoop O, Pories WJ et al. (1986) Studies on the mechanism of insulin resistance in the liver from humans with non-insulin-dependent diabetes. J Clin Invest 78: 249–258
Arner P, Pollare T, Lithell H, Livingston JN (1987) Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 437–440
Obermaier-Kusser B, White MF, Pongratz D, Su Z, Ermel B, Mühlbacher C, Häring HU (1989) A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. J Biol Chem 264: 9497–9564
Häring HU, Machicao F, Kirsch D et al. (1984) Protein kinase activity of the insulin receptor from muscle. FEBS Lett 176: 229–234
Taylor SI, Marcus-Samuels B, Ryan-Young J, Leventhal S, Elders MJ (1986) Genetics of the insulin receptor defect in a patient with extreme insulin resistance. J Clin Endocrinol Metab 62: 1130–1135
Cox N, Epstein PA, Spielmann RS (1989) Linkage studies on NIDDM and the insulin and insulin receptor genes. Diabetes 38: 653–658
Permutt MA, McGill J, Elbein SC, Province M, Bogardus C (1989) Insulin receptor gene polymorphisms (RFLPs) in American Blacks and Pima Indians: an assessment of the use of RFLPs in evaluating a candidate locus for NIDDM. Proceedings of the 3rd Nordisk Insulin Symposium “Genes and gene products in the development of diabetes mellitus”. Elsevier, Amsterdam, pp 249–262
Vogt B, Seino W, Whittaker J, Obermaier-Kusser B, Häring HU (1989) Reduced insulin-receptor kinase activity of Type 1 (insulin-dependent) diabetic patients is not due to a mutation in exon 20 of the IRK gene. Diabetologia 32: 554 (Abstract)
Moller DE, Yokota A, Flier JS (1989) Normal insulin receptor cDNA sequence in Pima Indians with NIDDM. Diabetes 38: 1496–1500
Ober C, Xiang KS, Thisted RA, Indovina KA, Wason CJ, Dooley S (1989) Increased risk for gestational diabetes mellitus associated with insulin receptor and insulin like growth factor II restriction fragment length polymorphisms. Genet Epidemiol 6: 559–569
Mosthaf L, Vogt B, Häring HU, Ullrich A (1991) Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. Proc Natl Acad Sci USA 88: 4728–4730
Bulangu LN, Ossowski VM, Bogardus C, Mott D (1990) Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. Am J Physiol 258: E964-E974
Author information
Authors and Affiliations
Additional information
Given as the Minkowski Lecture, EASD Meeting, Lisbon, Portugal 1989.
Rights and permissions
About this article
Cite this article
Häring, H.U. The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 34, 848–861 (1991). https://doi.org/10.1007/BF00400192
Issue Date:
DOI: https://doi.org/10.1007/BF00400192